Abstract
Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI
| Original language | English |
|---|---|
| Pages (from-to) | 382-389 |
| Number of pages | 8 |
| Journal | Annals of the Rheumatic Diseases |
| Volume | 75 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Rheumatology
- Immunology
- Biochemistry, Genetics and Molecular Biology(all)
- Immunology and Allergy
Cite this
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). / Seror, Raphaèle; Bootsma, Hendrika; Saraux, Alain; Bowman, Simon J.; Theander, Elke; Brun, Johan G.; Baron, Gabriel; Le Guern, Véronique; Devauchelle-Pensec, Valérie; Ramos-Casals, Manel; Valim, Valeria; Dörner, Thomas; Tzioufas, Athanasios; Gottenberg, Jacques Eric; Laqué, Roser Solans; Mandl, Thomas; Hachulla, Eric; Sivils, Kathy L.; Ng, Wan Fai; Fauchais, Anne Laure; Bombardieri, Stefano; Priori, Roberta; Bartoloni, Elena; Goeb, Vincent; Praprotnik, Sonja; Sumida, Takayuki; Nishiyama, Sumusu; Caporali, Roberto; Kruize, Aike A.; Vollenweider, Cristina; Ravaud, Philippe; Meiners, Petra; Brito-Zerón, Pilar; Vitali, Claudio; Mariette, Xavier; Gerli, Roberto; Kallenberg, Cees; De Vita, Salvatore; Demoulins, Frederic; Montecucco, Carlomaurizio; Tomsic, Matija; Scofield, Hal; Valesini, Guido.
In: Annals of the Rheumatic Diseases, Vol. 75, No. 2, 01.02.2016, p. 382-389.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
AU - Seror, Raphaèle
AU - Bootsma, Hendrika
AU - Saraux, Alain
AU - Bowman, Simon J.
AU - Theander, Elke
AU - Brun, Johan G.
AU - Baron, Gabriel
AU - Le Guern, Véronique
AU - Devauchelle-Pensec, Valérie
AU - Ramos-Casals, Manel
AU - Valim, Valeria
AU - Dörner, Thomas
AU - Tzioufas, Athanasios
AU - Gottenberg, Jacques Eric
AU - Laqué, Roser Solans
AU - Mandl, Thomas
AU - Hachulla, Eric
AU - Sivils, Kathy L.
AU - Ng, Wan Fai
AU - Fauchais, Anne Laure
AU - Bombardieri, Stefano
AU - Priori, Roberta
AU - Bartoloni, Elena
AU - Goeb, Vincent
AU - Praprotnik, Sonja
AU - Sumida, Takayuki
AU - Nishiyama, Sumusu
AU - Caporali, Roberto
AU - Kruize, Aike A.
AU - Vollenweider, Cristina
AU - Ravaud, Philippe
AU - Meiners, Petra
AU - Brito-Zerón, Pilar
AU - Vitali, Claudio
AU - Mariette, Xavier
AU - Gerli, Roberto
AU - Kallenberg, Cees
AU - De Vita, Salvatore
AU - Demoulins, Frederic
AU - Montecucco, Carlomaurizio
AU - Tomsic, Matija
AU - Scofield, Hal
AU - Valesini, Guido
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI
AB - Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI
UR - http://www.scopus.com/inward/record.url?scp=84954398507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84954398507&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2014-206008
DO - 10.1136/annrheumdis-2014-206008
M3 - Article
AN - SCOPUS:84954398507
VL - 75
SP - 382
EP - 389
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 0003-4967
IS - 2
ER -